Table 2 Symptomatic population
From: Testicular microlithiasis and testicular tumor: a review of the literature
Author | Year | N = S | Presence of TML | TML prevalence | No TML | ||
|---|---|---|---|---|---|---|---|
Tumor | Total | Tumor | Total | ||||
Pedersen et al. [12] N = 1538 | 2017 | 1538 | 8 | 197 | 12.8% | 25 | 1358 |
Richenberg et al. [5] N = 2656 | 2015 | 2656 | 0 | 51 | 1.9% | 0 | 2605 |
Volokhina et al. [13] N = 2266 | 2014 | 2266 | 1 | 87 | 3.8% | 8 | 2179 |
Deganello et al. [14] N = 516 | 2012 | 516 | 1 | 45 | 8.7% | 0 | 474 |
Kosan et al. [15] N = 197 | 2007 | 197 | 3 | 21 | 10.6% | 1 | 176 |
Ahmad et al. [16] N = 4256 | 2007 | 4259 | 3 | 32 | 0.8% | 80 | 4227 |
Pourbagher et al. [17] N = 5263 | 2005 | 5263 | 4 | 40 | 0.8% | 0 | 5223 |
Ringdahl et al. [18] N = 160 | 2004 | 160 | 4 | 12 | 8% | 2 | 148 |
Bach et al. [19] N = 528 | 2003 | 528 | 12 | 48 | 9% | 36 | 480 |
Middleton et al. [20] N = 1079 | 2002 | 1079 | 3 | 40 | 3.7% | 3 | 884 |
Derogee et al. [21] N = 1535 | 2001 | 1535 | 30 | 54 | 1.8% | 31 | 1472 |
Skyrme et al. [22] N = 2215 | 2000 | 2215 | 5 | 34 | 1.4% | 24 | 2181 |
Total | 22,212 | 74 | 661 | 5.3% | 210 | 21,407 | |